Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1476-1482, 2003; 10.1373/49.9.1476
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Infante-Rivard, C.
Right arrow Articles by Théorêt, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Infante-Rivard, C.
Right arrow Articles by Théorêt, Y.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Nutrition
Right arrow Hemostasis and Thrombosis
Right arrow Proteomics and Protein Markers
Right arrow Lipids, Lipoproteins, and Cardiovascular Risk Factors
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:1476-1482.)
© 2003 American Association for Clinical Chemistry, Inc.


Hemostasis and Thrombosis

Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction

Claire Infante-Rivard1,2,a, Georges-Etienne Rivard2,3, Robert Gauthier4 and Yves Théorêt2,3

1 Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, Montréal, Province of Québec, H3A 1A3 Canada.

2 Research Centre,
3 Division of Hematology and Oncology, Department of Pediatrics, and
4 Department of Obstetrics, Centre Hospitalier Universitaire Mère-Enfant (CHUME), Hôpital Sainte-Justine, Université de Montréal, Montréal, H3T 1C5 Canada.

aAddress correspondence to this author at: Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, 1130 Pine Ave. West, Montréal, Province of Québec, H3A 1A3 Canada. Fax 514-398-7435; e-mail claire.infante-rivard{at}mcgill.ca.

Background: Moderate hyperhomocysteinemia is considered a risk factor for thrombosis and atherosclerosis. We hypothesized that higher maternal and newborn homocysteine concentrations in plasma would increase the risk of intrauterine growth restriction through placental thrombosis.

Methods: We carried out a case-control study that included all cases born at our institution over a 2-year period whose birthweight was below the 10th percentiles for gestational age and sex according to Canadian norms; controls were born at the same period and institution at or above the 10th percentiles and were matched on gestational age, race, and sex. Homocysteine was measured in cord and maternal blood. The analysis included 483 case and 468 control mothers and 409 case and 438 control newborns.

Results: Homocysteine values were largely <15 µmol/L. Contrary to expectation, within that range of values, increased plasma homocysteine, particularly in the mother, was protective against intrauterine growth restriction. With the case/control status as the outcome, the estimated odds ratio was 0.37 (95% confidence interval, 0.24–0.58) for a 5 µmol/L unit difference on the maternal homocysteine scale. With birthweight as the outcome, the estimated increase was 178.1 g (95% confidence interval, 92.5–263.7 g) for every 5 µmol/L unit increase in maternal homocysteine. Results were similar using newborn homocysteine concentrations.

Conclusions: The data suggest that, in contrast to the proposed hypothesis, mothers with small babies have lower homocysteine concentrations than those giving birth to larger ones.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
L. Dodds, D. B. Fell, K. C. Dooley, B. A. Armson, A. C. Allen, B. A. Nassar, S. Perkins, and K.S. Joseph
Effect of Homocysteine Concentration in Early Pregnancy on Gestational Hypertensive Disorders and Other Pregnancy Outcomes
Clin. Chem., February 1, 2008; 54(2): 326 - 334.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. Tamura and M. F. Picciano
Folate and human reproduction
Am. J. Clinical Nutrition, May 1, 2006; 83(5): 993 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. M. Ueland and S. E. Vollset
Homocysteine and Folate in Pregnancy
Clin. Chem., August 1, 2004; 50(8): 1293 - 1295.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. M. Murphy, J. M. Scott, V. Arija, A. M. Molloy, and J. D. Fernandez-Ballart
Maternal Homocysteine before Conception and throughout Pregnancy Predicts Fetal Homocysteine and Birth Weight
Clin. Chem., August 1, 2004; 50(8): 1406 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Infante-Rivard and G.-E. Rivard
Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction: Response
Clin. Chem., April 1, 2004; 50(4): 784 - 785.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Y. Moridani
Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction
Clin. Chem., April 1, 2004; 50(4): 782 - 784.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Cattaneo
Homocysteine and the Risk of Intrauterine Growth Retardation
Clin. Chem., September 1, 2003; 49(9): 1432 - 1433.
[Full Text] [PDF]

eLetters:

Read all eLetters

Unexpected Relationship between Plasma Homocysteine and Intrauterine Growth Restriction.
Majid Y Moridani
Clinical Chemistry Online, 22 Dec 2003 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.